SLC3A2 itself is not associated with human dyslipidemia, but several SLC7 dimer partners are, suggesting the link between slc3a2a function and B-lp metabolism may be specific to a subset of transported substrates (e.g., amino acids), tissue expression patterns, and/or subcellular localization. This evidence concerns the gene SLC3A2 and metabolic syndrome.